Health Dictionary
Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
PCDH17
Introduction
Protocadherin-17 is a protein that in humans is encoded by the PCDH17 gene.[1][2]
This gene belongs to the protocadherin gene family, a subfamily of the cadherin superfamily. The encoded protein contains six extracellular cadherin domains, a transmembrane domain, and a cytoplasmic tail differing from those of the classical cadherins. The encoded protein may play a role in the establishment and function of specific cell-cell connections in the brain.[2] PCDH17 promoter methylation is found to be closely associated with bladder cancer malignancy [3]
References
References
- ↑ Nollet F, Kools P, van Roy F (Jul 2000). “Phylogenetic analysis of the cadherin superfamily allows identification of six major subfamilies besides several solitary members”. J Mol Biol. 299 (3): 551–72. doi:10.1006/jmbi.2000.3777. PMID 10835267.
- ↑ 2.0 2.1 “Entrez Gene: PCDH17 protocadherin 17”.
- ↑ Wang XB (Apr 2014). “Protocadherin 17 promoter methylation in tumour tissue from patients with bladder transitional cell carcinoma”. J Int Med Res. 42 (2): 292–9. doi:10.1177/0300060513504364. PMID 24567353.
Further reading
Further reading
- Yagi T, Takeichi M (2000). “Cadherin superfamily genes: functions, genomic organization, and neurologic diversity”. Genes Dev. 14 (10): 1169–80. doi:10.1101/gad.14.10.1169 (inactive 2018-11-07). PMID 10817752.
- Suzuki ST (2000). “Recent progress in protocadherin research”. Exp. Cell Res. 261 (1): 13–8. doi:10.1006/excr.2000.5039. PMID 11082270.
- Wu Q, Maniatis T (2000). “Large exons encoding multiple ectodomains are a characteristic feature of protocadherin genes”. Proc. Natl. Acad. Sci. U.S.A. 97 (7): 3124–9. doi:10.1073/pnas.060027397. PMC 16203. PMID 10716726.
- Strausberg RL, Feingold EA, Grouse LH, et al. (2003). “Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences”. Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. doi:10.1073/pnas.242603899. PMC 139241. PMID 12477932.
- Ota T, Suzuki Y, Nishikawa T, et al. (2004). “Complete sequencing and characterization of 21,243 full-length human cDNAs”. Nat. Genet. 36 (1): 40–5. doi:10.1038/ng1285. PMID 14702039.
- Dunham A, Matthews LH, Burton J, et al. (2004). “The DNA sequence and analysis of human chromosome 13”. Nature. 428 (6982): 522–8. doi:10.1038/nature02379. PMC 2665288. PMID 15057823.
- Suzuki Y, Yamashita R, Shirota M, et al. (2004). “Sequence Comparison of Human and Mouse Genes Reveals a Homologous Block Structure in the Promoter Regions”. Genome Res. 14 (9): 1711–8. doi:10.1101/gr.2435604. PMC 515316. PMID 15342556.
- Gerhard DS, Wagner L, Feingold EA, et al. (2004). “The Status, Quality, and Expansion of the NIH Full-Length cDNA Project: The Mammalian Gene Collection (MGC)”. Genome Res. 14 (10B): 2121–7. doi:10.1101/gr.2596504. PMC 528928. PMID 15489334.
- Kimura K, Wakamatsu A, Suzuki Y, et al. (2006). “Diversification of transcriptional modulation: Large-scale identification and characterization of putative alternative promoters of human genes”. Genome Res. 16 (1): 55–65. doi:10.1101/gr.4039406. PMC 1356129. PMID 16344560.
- Szafranski K, Schindler S, Taudien S, et al. (2007). “Violating the splicing rules: TG dinucleotides function as alternative 3′ splice sites in U2-dependent introns”. Genome Biology. 8 (8): R154. doi:10.1186/gb-2007-8-8-r154. PMCÂ 2374985. PMIDÂ 17672918.